RAD001 and zoledronic acid in renal cell carcinoma patients with bone metastases (RAZOR): A randomized phase II trial

被引：0
|
作者：
Broom, Reuben James
Hinder, Vicky
Sharples, Katrina
Proctor, Janie
Duffey, Steven
Pollard, Stephanie
Fong, Peter C. C.
Forgeson, Garry
Harris, Dean Laurence
Jameson, Michael B.
O'Donnell, Anne
North, Richard T.
Deva, Sanjeev
Hanning, Fritha J.
Grey, Andrew
Findlay, Michael P. N.
机构：
[1] Auckland City Hosp, Auckland, New Zealand
[2] Canc Trials New Zealand, Auckland, New Zealand
[3] Canc Trials New Zealand, Dunedin, New Zealand
[4] Univ Auckland, Canc Trials New Zealand, Auckland 1, New Zealand
[5] Palmerston North Hosp, Palmerston North, New Zealand
[6] Christchurch Hosp, Christchurch, New Zealand
[7] Waikato Hosp, Hamilton, New Zealand
[8] Capital & Coast Hlth Wellington Hosp, Wellington, New Zealand
[9] Tauranga Hosp, Tauranga, New Zealand
[10] Univ Auckland, Auckland 1, New Zealand
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15054
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] RAD001 and zoledronic acid in patients with renal cell carcinoma with bone metastases (RAZOR): A randomized phase II trial
    Broom, Reuben James
    Hinder, Vicky
    Sharples, Katrina
    Proctor, Janie
    Duffey, Steven
    Pollard, Stephanie
    Fong, Peter C. C.
    Forgeson, Garry
    O'Donnell, Anne
    Harris, Dean Laurence
    Deva, Sanjeev
    Jameson, Michael B.
    North, Richard T.
    Grey, Andrew
    Findlay, Michael P. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [2] RAD001 AND ZOLEDRONIC ACID IN RENAL CELL CARCINOMA PATIENTS WITH BONE METASTASES (RAZOR) - A RANDOMIZED PHASE II TRIAL
    Broom, R. J.
    Hinder, V.
    Sharples, K.
    Proctor, J.
    Duffey, S.
    Pollard, S.
    Fong, P. C. C.
    Forgeson, G.
    Harris, D. L.
    Jameson, M. B.
    O'Donnell, A.
    North, R. T.
    Deva, S.
    Hanning, F. J.
    Grey, A.
    Findlay, M. P. N.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 24 - 24
  • [3] A phase II trial of RAD001 in patients (Pts) with metastatic renal cell carcinoma (MRCC)
    Jac, J.
    Giessinger, S.
    Khan, M.
    Willis, J.
    Chiang, S.
    Amato, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] A phase II trial of RAD001 in patients (Pts) with metastatic renal cell carcinoma (MRCC).
    Amato, R. J.
    Misellati, A.
    Khan, M.
    Chiang, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 224S - 224S
  • [5] A phase II trial of RAD001 in patients (PTS) with metastatic renal cell carcinoma (MRCC)
    Amato, R.
    Jac, J.
    Giessinger, S.
    Khan, M.
    Willis, J.
    Chiang, S.
    CANCER INVESTIGATION, 2007, 25 : 20 - 21
  • [6] Everolimus and Zoledronic Acid in Patients With Renal Cell Carcinoma With Bone Metastases: A Randomized First-Line Phase II Trial
    Broom, Reuben J.
    Hinder, Victoria
    Sharples, Katrina
    Proctor, Janie
    Duffey, Steven
    Pollard, Stephanie
    Fong, Peter C. C.
    Forgeson, Garry
    Harris, Dean L.
    Jameson, Michael B.
    O'Donnell, Anne
    North, Richard T.
    Deva, Sanjeev
    Hanning, Fritha J.
    Grey, Andrew
    Findlay, Michael P. N.
    CLINICAL GENITOURINARY CANCER, 2015, 13 (01) : 50 - 58
  • [7] Phase II trial of RAD001 in renal cell carcinoma patients with non-clear cell histology.
    Koh, Youngil
    Kim, Ji Yeon
    Lim, Ho Yeong
    Ahn, Jin-Hee
    Lee, Jae-Lyun
    Rha, Sun Young
    Kim, YuJung
    Kim, Tae Min
    Lee, Se-Hoon
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Phase I trial of RAD001 (everolimus) plus sunitinib in patients with metastatic renal cell carcinoma
    Kroog, G. S.
    Feldman, D. R.
    Kondagunta, G. V.
    Ginsberg, M. S.
    Fischer, P. M.
    Trinos, M. J.
    Patil, S.
    Ishill, N. M.
    Motzer, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Administration of RAD001 in patients with metastasized renal cell carcinoma
    Gruenwald, V.
    Gschwend, J.
    ONKOLOGE, 2009, 15 (05): : 512 - +
  • [10] Phase II study of bevacizumab and everolimus (RAD001) in the treatment of advanced renal cell carcinoma (RCC)
    Whorf, R. C.
    Hainsworth, J. D.
    Spigel, D. R.
    Yardley, D. A.
    Burris, H. A., III
    Waterhouse, D. M.
    Vazquez, E. R.
    Greco, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345